Overview

Darunavir and Rilpivirine Interactions With Levonorgestrel Implant

Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the pharmacokinetic properties of Rilpivirine and Darunavir when used in combination with Levonorgestrel
Phase:
Phase 2
Details
Lead Sponsor:
Makerere University
Collaborators:
University of Liverpool
University of Nebraska
University of Pittsburgh
Treatments:
Darunavir
Levonorgestrel
Rilpivirine
Ritonavir